Home LiteratureArticle Details
PMID: 2562982 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.

The Journal of experimental medicine ·Vol. 169 ·No. 2 ·1989-02-01 ·Pages 457-67

Klarnet JP, Kern DE, Okuno K, Holt C, Lilly F, Greenberg PD

Abstract

Immunization of C57BL/6 (B6) mice with FBL, a Friend murine leukemia virus (F-MuLV), induces both tumor-specific cytolytic CD8+ (CTL) and lymphokine-producing CD4+ Th that are effective in adoptive therapy of B6 mice bearing disseminated FBL leukemia. The current study evaluated the F-MuLV antigenic determinants expressed on FBL that are recognized by FBL-reactive CD8+ and CD4+ T cells. To identify the specificity of the FBL-reactive CD8+ CTL, Fisher rat embryo fibroblast (FRE) cells transfected with plasmids encoding F-MuLV gag or envelope (env) gene products plus the class I-restricting element Db were utilized. FBL-reactive CTL recognized FRE target cells transfected with the F-MuLV gag-encoded gene products, but failed to recognize targets expressing F-MuLV env. Attempts to generate env-specific CD8+ CTL by immunization with a recombinant vaccinia virus containing an inserted F-MuLV env gene were unsuccessful, despite the generation of a cytolytic response to vaccinia epitopes, implying that B6 mice fail to generate CD8+ CTL to env determinants. By contrast, CD4+ Th clones recognized FRE target cells transfected with env and not gag genes, and immunization with the recombinant vaccinia virus induced an env-specific CD4+ T cell response. These data show that in a Friend retrovirus-induced tumor model in which tumor rejection can be mediated by either CTL or Th, antigens derived from discrete retroviral proteins are predominantly responsible for activation of each T cell subset.

MeSH Terms
Animals Antigens, Viral/genetics,immunology CD4-Positive T-Lymphocytes/immunology Cloning, Molecular Cytotoxicity, Immunologic Friend murine leukemia virus/immunology Gene Products, gag Histocompatibility Antigens Class II/immunology In Vitro Techniques Lymphocyte Activation Mice Retroviridae Proteins/genetics,immunology T-Lymphocytes, Cytotoxic/immunology T-Lymphocytes, Helper-Inducer/immunology Transfection Viral Envelope Proteins/immunology
Chemicals
Antigens, Viral Gene Products, gag Histocompatibility Antigens Class II Retroviridae Proteins Viral Envelope Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Klarnet J P
Department of Medicine, University of Washington, Seattle.
Kern D E
Okuno K
Holt C
Lilly F
Greenberg P D
References (41)
41 references, click to expand
  1. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Nature. 1987 Jul 23-29;328(6128):345-8 PMID: 3496541
  2. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    J Immunol. 1986 Jun 1;136(11):4303-10 PMID: 2422280
  3. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.
    Immunol Rev. 1987 Aug;98:95-114 PMID: 2443444
  4. Cytolytic T lymphocytes.
    Annu Rev Immunol. 1983;1:273-306 PMID: 6085785
  5. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
    J Immunol. 1987 Jun 1;138(11):4012-7 PMID: 3108381
  6. Characterization of mouse monoclonal antibodies specific for Friend murine leukemia virus-induced erythroleukemia cells: friend-specific and FMR-specific antigens.
    Virology. 1981 Jul 15;112(1):131-44 PMID: 6787798
  7. T cell-mediated immunity to oncornavirus-induced tumors. I. Ly phenotype of precursor and effector cytolytic T lymphocytes.
    J Immunol. 1980 Feb;124(2):846-50 PMID: 6243332
  8. Retrovirus antigens recognized by cytolytic T lymphocytes activate tumor rejection in vivo.
    Cell. 1987 Jan 30;48(2):231-40 PMID: 3026637
  9. Identification of an FMR cell surface antigen associated with murine leukemia virus-infected cells.
    J Virol. 1978 Jun;26(3):805-12 PMID: 78990
  10. Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.
    J Immunol. 1986 Mar 1;136(5):1917-22 PMID: 3485134
  11. Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins.
    J Immunol. 1987 Aug 15;139(4):988-90 PMID: 3497202
  12. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.
    N Engl J Med. 1982 Jul 1;307(1):7-13 PMID: 6281647
  13. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
    Science. 1986 Nov 7;234(4777):728-31 PMID: 3490689
  14. Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.
    J Immunol. 1984 Apr;132(4):2117-22 PMID: 6607955
  15. Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.
    J Immunol. 1980 Aug;125(2):711-4 PMID: 6156213
  16. The interaction between protein-derived immunogenic peptides and Ia.
    Immunol Rev. 1987 Aug;98:115-41 PMID: 3308686
  17. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.
    J Exp Med. 1983 Aug 1;158(2):303-16 PMID: 6193218
  18. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
    J Exp Med. 1985 May 1;161(5):1122-34 PMID: 3921652
  19. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
    J Exp Med. 1983 May 1;157(5):1448-60 PMID: 6189937
  20. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.
    J Exp Med. 1981 Sep 1;154(3):952-63 PMID: 6974221
  21. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.
    J Exp Med. 1984 Sep 1;160(3):814-26 PMID: 6206190
  22. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Cancer Res. 1985 Jan;45(1):14-8 PMID: 3855280
  23. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.
    Nature. 1988 Apr 28;332(6167):840-3 PMID: 3258650
  24. Vaccinia virus expression vectors.
    Annu Rev Immunol. 1987;5:305-24 PMID: 2439103
  25. H-2 restriction of adoptive immunotherapy of advanced tumors.
    J Immunol. 1981 Jun;126(6):2100-3 PMID: 6453154
  26. Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.
    J Exp Med. 1980 Oct 1;152(4):823-41 PMID: 6968337
  27. Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.
    J Exp Med. 1986 Jul 1;164(1):211-26 PMID: 2425028
  28. Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone.
    Proc Natl Acad Sci U S A. 1982 Sep;79(17):5384-7 PMID: 6982472
  29. The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site.
    Immunol Rev. 1987 Aug;98:53-73 PMID: 2443442
  30. Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
    J Immunol. 1988 Oct 15;141(8):2824-30 PMID: 2459230
  31. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    J Immunol. 1985 Jul;135(1):703-13 PMID: 2582053
  32. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia.
    J Exp Med. 1957 Apr 1;105(4):307-18 PMID: 13416470
  33. Biochemical characterization of class II bovine major histocompatibility complex antigens using cross-species reactive antibodies.
    Immunogenetics. 1982;15(6):621-4 PMID: 6179867
  34. Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.
    J Exp Med. 1977 Oct 1;146(4):909-22 PMID: 197198
  35. Type-specific radioimmunoassays for the gp70s of mink cell focus-inducing murine leukemia viruses: expression of a cross-reacting antigen in cells infected with the Friend strain of the spleen focus-forming virus.
    J Exp Med. 1978 Sep 1;148(3):654-63 PMID: 702051
  36. Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.
    J Exp Med. 1986 May 1;163(5):1100-12 PMID: 3084700
  37. Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.
    J Immunol. 1987 Nov 1;139(9):2880-7 PMID: 2959723
  38. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses.
    Nature. 1986 Sep 25-Oct 1;323(6086):344-6 PMID: 3093891
  39. Adoptive chemoimmunotherapy of murine leukemia with helper T lymphocyte clones.
    J Immunol. 1987 Nov 1;139(9):3166-70 PMID: 2822805
  40. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.
    J Exp Med. 1980 Jan 1;151(1):69-80 PMID: 6444236
  41. Immunology. The ins and outs of antigen processing and presentation.
    Nature. 1986 Aug 21-27;322(6081):687-9 PMID: 3489186
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1989-02-01
Pages
457-67
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189204
Subset
IM
Grants
NCI NIH HHS · CA-01192 · United States
NCI NIH HHS · CA-30588 · United States
NCI NIH HHS · CA-33084 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]